Drug intelligence / Profile preview

pterin-6-yl-methyl-monophosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Pterin‑6‑yl‑methyl‑monophosphate is a synthetic small molecule belonging to the class of pterins and derivatives. It features a pterin ring system linked via a methylene group to a monophosphate moiety. This compound is primarily used as an experimental or discovery agent in biochemical research and drug discovery. Its main known biological activity is as an inhibitor of bacterial dihydropteroate synthetase (DHPS), an enzyme essential for folate biosynthesis in bacteria but absent in mammals. By inhibiting DHPS, it can disrupt folate production, which is critical for cell growth and survival in prokaryotes[1][5][7]. There are no approved clinical indications or marketed formulations for this compound.

Other names
((2-amino-4-oxo-3,4-dihydropteridin-6-yl)methoxy)phosphonic acid[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methoxy]phosphonic acid6-hydroxymethylpterin monophosphate(2-amino-4-oxo–3H-pteridin–6–yl)methyl dihydrogen phosphate
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on pterin-6-yl-methyl-monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pterin-6-yl-methyl-monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call